Rethinking Drug Safety Signal Detection and Causality Assessment in the Age of AI
This underscores a critical risk for the increasing proposals to use AI in pharmacovigilance (PV) (Sahni et al, 2023): when key information is missing ...
Read the original at Frontiers ↗
- Topics
- AI Safety & Existential RiskHealthcare
- Tracked via
- “AI Risks”